Bachem Holding AG (BANB.SW)

Swiss · Healthcare · Biotechnology
76.20 CHF-4.39%As of 2026-11-22 · CHF
Last session low 75.40 CHFLast session high 79.75 CHF
52-week low 49.52 CHF52-week high 86.00 CHF
Market cap (USD)
$6.80B
Sector
Healthcare
P/E (TTM)
38.5x
Dividend yield
1.18%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CHF.

IndicatorValueReading
RSI (14)37.2In the neutral range (30 to 70)
MACD (12, 26, 9)-0.95Below its signal line (-0.49); histogram -0.46
Bollinger %B (20, 2)1%Inside the bands (76.15 to 85.33)
SMA 2080.74Price is 5.6% below
SMA 5080.86Price is 5.8% below
SMA 20072.70Price is 4.8% above
ATR (20)3.20% of priceAverage true range per day
52-week position73%In the upper part of the 49.52 to 86.00 range

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs).

Latest fiscal yearEnded 2025-12-31: revenue of 695.07M CHF and an operating margin of 24.1%.

More in Biotechnology